REPAMADE V1/0.2 (Repaglinide (1mg) + Voglibose (0.2mg))

Repamade V Tablet 1mg/0.2mg is formulated as a combination of two medications aimed at managing type 2 diabetes mellitus. This medication assists in regulating elevated blood sugar levels following meals. It is particularly beneficial for individuals who find that other comparable medications, in conjunction with a controlled diet, do not adequately manage their blood sugar levels. The administration of Repamade V Tablet 1mg/0.2mg is advised to be done shortly after meals, with the specific dosage determined by a healthcare professional. It is crucial not to discontinue use without first consulting a doctor, as doing so could lead to an increase in blood sugar levels, which may pose serious health risks, including potential kidney damage and vision impairment. If a dose is missed, it is recommended to wait until the next meal instead of taking the missed dose in between meals, and one should never double the dose to compensate. This medication should be part of a comprehensive treatment program that incorporates a healthy diet, consistent physical activity, and weight management as directed by your healthcare provider. Monitoring of blood sugar levels is essential while on this medication. Prior to starting treatment, patients should inform their doctor of any existing kidney or liver issues or urinary tract infections, as well as if they are taking diuretics. Pregnant and breastfeeding women should also seek medical advice before using this medication, and it is advisable to limit alcohol consumption during treatment, given the potential for increased side effects.